Methods of using adipose tissue-derived cells in augmenting autologous fat transfer

Details for Australian Patent Application No. 2004260638 (hide)

Owner Macropore Biosurgery Inc.

Inventors Hedrick, Marc H.; Fraser, John K.

Agent Spruson & Ferguson

Pub. Number AU-A-2004260638

PCT Pub. Number WO2005/011569

Priority 60/479,418 18.06.03 US

Filing date 18 June 2004

Wipo publication date 10 February 2005

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011569 Priority application(s): WO2005/011569

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260642-2-methylene-19-nor-20(S)-25-methyl-1a lpha-hydroxycalciferol and its uses

2004260636-5-substituted 2H-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor RUP25 for the treatment of dyslipidemia and related diseases